Internal Medicine in Oneonta, NY
11 verified internal medicine doctors in Oneonta.
Internists specialize in the prevention, diagnosis, and treatment of adult diseases, often coordinating complex or chronic conditions across multiple systems.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New York State Board for Professional Medical Conduct
Dr. Todd Bitterman, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Todd Churchill, DO
Internal Medicine
CMS Open Payments· $45.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$45.10
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total ranks around the 71th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to Todd Churchill do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Gregory Xanthaky, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Walker, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Levenstein, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Deanna Palumbo, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Oxley, MD
Internal Medicine
CMS Open Payments· $237.63 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$237.63
Total received
10
Transactions
5
Paying companies
Top paying companies
Among the 183,896 internal medicine doctors we've analyzed, about 37% received any industry payment (median $195 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US internal medicine doctors.
Payments to David Oxley do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Stephen Rollo, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sajjadali Chagani, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sneha Kanduri Hanumantharayudu, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Daniela Tovar Villada, MD
Internal Medicine
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.